• Chairman and CEO of Cigna Group (NYSE: CI), Cordani David, increases his stake in the company, signaling confidence amidst stock price volatility.
• Cigna introduces a rebate-free pharmacy benefit model through its Evernorth division to address cost concerns and improve economic terms for partners.
• Despite a recent drop in stock price following its Q3 earnings call, Cigna shows signs of recovery and demonstrates resilience in a competitive health services industry.

On November 3, 2025, Cordani David, Chairman and CEO of Cigna Group (NYSE: CI), purchased 4,134 shares of the company's common stock at $241.88 per share. This acquisition increased his total ownership to 157,935 shares. Cigna, a major player in the health services industry, offers a range of insurance products and services, competing with companies like UnitedHealth Group and Anthem.

Cigna recently faced a significant drop in its stock price following its third-quarter 2025 earnings call. The company revealed expected margin pressure in its pharmacy benefit services segment over the next two years, leading to a 17% decline in CI stock, as highlighted by the Wall Street Journal. Despite this, Cigna reported an increase in both profit and revenue for the quarter, driven by growth in its Evernorth division.

To address cost concerns, Evernorth introduced a rebate-free pharmacy benefit model. This model aims to lower costs and will be adopted by Cigna Healthcare for its fully insured lives starting in 2027. By 2028, it will become the standard for all Evernorth pharmacy benefits clients. This move is part of Cigna's strategy to improve economic terms for partners involved in government programs.

Despite the recent stock price drop, CI shares have shown some recovery, currently priced at $253.12, with a 3.56% rise today. The stock has seen a low of $239.51 and a high of $253.48 during the day's trading. Over the past year, CI's stock has fluctuated between a high of $350 and a low of $239.51, with a market capitalization of approximately $67.6 billion.

Cigna's proactive approach to addressing financial pressures and enhancing transparency reflects its commitment to long-term strategic clients. The company's efforts to adapt to industry challenges and maintain growth in its pharmacy-benefit business demonstrate its resilience in a competitive market.